Achieve Life Sciences (ACHV) Cash from Restructuring (2012 - 2015)

Achieve Life Sciences (ACHV) has 5 years of Cash from Restructuring data on file, last reported at -$194000.0 in Q1 2015.

• Quarterly Cash from Restructuring fell 2.65% year-over-year to -$194000.0 in Q1 2015, while the trailing twelve-month figure through Dec 2015 was -$194000.0 (up 77.15% YoY) and the FY2015 annual result came in at -$194000.0, up 75.29% from the prior year.
• Cash from Restructuring improved to -$194000.0 in Q1 2015, from -$267000.0 in the prior quarter.
• In the past five years, Cash from Restructuring ranged from a high of -$164000.0 in Q1 2013 to a low of -$1.7 million in Q4 2012.
• A 4-year average of -$338000.0 and a median of -$191500.0 in 2014 frame the typical range for Cash from Restructuring.
• Annual changes were most pronounced in 2013 — Cash from Restructuring surged 89.38% — and 2014, when it slumped 51.7%.
• Tracing ACHV's Cash from Restructuring over 4 years: stood at -$1.7 million in 2012, then surged by 89.38% to -$176000.0 in 2013, then tumbled by 51.7% to -$267000.0 in 2014, then increased by 27.34% to -$194000.0 in 2015.
• The last three Cash from Restructuring figures came in at -$194000.0 (Q1 2015), -$267000.0 (Q4 2014), and -$199000.0 (Q3 2014), per Business Quant data.